Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019199838> ?p ?o ?g. }
- W2019199838 endingPage "168" @default.
- W2019199838 startingPage "159" @default.
- W2019199838 abstract "The aim of the study was the evaluation of anti-angiogenic activity of the combination of intermediate doses of thalidomide and dexamethasone in patients with refractory/relapsed myeloma. Twenty-five patients were included in the study. Microvessel density (MVD) was evaluated in marrow biopsies before and after treatment. Serum levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), tumor necrosis factor-alpha (TNF-α), which have angiogenic potential and interleukin-6 (IL-6), IL-1β, soluble IL-6 receptor (sIL-6R), and transforming growth factor-beta (TGF-β) which are involved in the disease biology, were measured before treatment and then every 2 weeks for 8 weeks. Pretreatment levels of MVD, VEGF, b-FGF, IL-6, sIL-6R were increased in the patients compared to controls. The overall response rate to therapy was 72%. The administration of the combined regimen produced a significant reduction in MVD in responders. However, an increase in serum levels of VEGF, b-FGF, IL-6, sIL-6R was observed post-treatment in responders. In contrast, serum levels of TNF-α, TGF-β, IL-1β did not differ between patients and controls and remained unchanged during the study. These results suggest that the combination of thalidomide plus dexamethasone is an effective treatment for myeloma reducing MVD marrow levels but not serum levels of angiogenic cytokines or cytokines implicated in myeloma biology. Copyright © 2005 John Wiley & Sons, Ltd." @default.
- W2019199838 created "2016-06-24" @default.
- W2019199838 creator A5021348455 @default.
- W2019199838 creator A5024004832 @default.
- W2019199838 creator A5029337337 @default.
- W2019199838 creator A5041407463 @default.
- W2019199838 creator A5043034719 @default.
- W2019199838 creator A5047242304 @default.
- W2019199838 creator A5053407676 @default.
- W2019199838 creator A5056053087 @default.
- W2019199838 creator A5075837874 @default.
- W2019199838 date "2004-12-01" @default.
- W2019199838 modified "2023-10-16" @default.
- W2019199838 title "The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma" @default.
- W2019199838 cites W1568733499 @default.
- W2019199838 cites W1580184585 @default.
- W2019199838 cites W179936999 @default.
- W2019199838 cites W1947748380 @default.
- W2019199838 cites W1969705003 @default.
- W2019199838 cites W1975311615 @default.
- W2019199838 cites W1978377409 @default.
- W2019199838 cites W1982034975 @default.
- W2019199838 cites W1984996099 @default.
- W2019199838 cites W1985147506 @default.
- W2019199838 cites W2003656890 @default.
- W2019199838 cites W2004810624 @default.
- W2019199838 cites W2013187395 @default.
- W2019199838 cites W2018206586 @default.
- W2019199838 cites W2022861980 @default.
- W2019199838 cites W2023147749 @default.
- W2019199838 cites W2025821693 @default.
- W2019199838 cites W2032156408 @default.
- W2019199838 cites W2039853752 @default.
- W2019199838 cites W2041170438 @default.
- W2019199838 cites W2051955486 @default.
- W2019199838 cites W2053166134 @default.
- W2019199838 cites W2054737897 @default.
- W2019199838 cites W2059873406 @default.
- W2019199838 cites W2078758435 @default.
- W2019199838 cites W2079067557 @default.
- W2019199838 cites W2091124435 @default.
- W2019199838 cites W2092430089 @default.
- W2019199838 cites W2102591890 @default.
- W2019199838 cites W2113101033 @default.
- W2019199838 cites W2119810076 @default.
- W2019199838 cites W2132242107 @default.
- W2019199838 cites W2133986577 @default.
- W2019199838 cites W2147124686 @default.
- W2019199838 cites W2169295136 @default.
- W2019199838 cites W2316160054 @default.
- W2019199838 cites W2329320378 @default.
- W2019199838 cites W2999700545 @default.
- W2019199838 doi "https://doi.org/10.1002/hon.738" @default.
- W2019199838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15991268" @default.
- W2019199838 hasPublicationYear "2004" @default.
- W2019199838 type Work @default.
- W2019199838 sameAs 2019199838 @default.
- W2019199838 citedByCount "25" @default.
- W2019199838 countsByYear W20191998382012 @default.
- W2019199838 countsByYear W20191998382013 @default.
- W2019199838 countsByYear W20191998382014 @default.
- W2019199838 countsByYear W20191998382015 @default.
- W2019199838 countsByYear W20191998382020 @default.
- W2019199838 countsByYear W20191998382023 @default.
- W2019199838 crossrefType "journal-article" @default.
- W2019199838 hasAuthorship W2019199838A5021348455 @default.
- W2019199838 hasAuthorship W2019199838A5024004832 @default.
- W2019199838 hasAuthorship W2019199838A5029337337 @default.
- W2019199838 hasAuthorship W2019199838A5041407463 @default.
- W2019199838 hasAuthorship W2019199838A5043034719 @default.
- W2019199838 hasAuthorship W2019199838A5047242304 @default.
- W2019199838 hasAuthorship W2019199838A5053407676 @default.
- W2019199838 hasAuthorship W2019199838A5056053087 @default.
- W2019199838 hasAuthorship W2019199838A5075837874 @default.
- W2019199838 hasConcept C126322002 @default.
- W2019199838 hasConcept C134018914 @default.
- W2019199838 hasConcept C167734588 @default.
- W2019199838 hasConcept C17991360 @default.
- W2019199838 hasConcept C2776364478 @default.
- W2019199838 hasConcept C2777025900 @default.
- W2019199838 hasConcept C2778690821 @default.
- W2019199838 hasConcept C2779609412 @default.
- W2019199838 hasConcept C2780007613 @default.
- W2019199838 hasConcept C2780394083 @default.
- W2019199838 hasConcept C2780401358 @default.
- W2019199838 hasConcept C71924100 @default.
- W2019199838 hasConceptScore W2019199838C126322002 @default.
- W2019199838 hasConceptScore W2019199838C134018914 @default.
- W2019199838 hasConceptScore W2019199838C167734588 @default.
- W2019199838 hasConceptScore W2019199838C17991360 @default.
- W2019199838 hasConceptScore W2019199838C2776364478 @default.
- W2019199838 hasConceptScore W2019199838C2777025900 @default.
- W2019199838 hasConceptScore W2019199838C2778690821 @default.
- W2019199838 hasConceptScore W2019199838C2779609412 @default.
- W2019199838 hasConceptScore W2019199838C2780007613 @default.
- W2019199838 hasConceptScore W2019199838C2780394083 @default.
- W2019199838 hasConceptScore W2019199838C2780401358 @default.
- W2019199838 hasConceptScore W2019199838C71924100 @default.